At Sequel, we believe better diabetes management isn’t just a business decision, but the right thing to do. Our mission bridges critical health disparities by making advanced diabetes management technology accessible to those who need it most, creating pathways to better care that might otherwise remain out of reach.
Our executive team brings decades of collective experience in healthcare technology, diabetes care, and benefit management, uniquely positioning us to be your trusted partner in diabetes management strategy.
SequelConnect was founded on the belief that people with an insulin dependency or deficiency deserve access to Automated Insulin Delivery systems. We look beyond traditional awareness and access channels into employee benefits to reach more people with diabetes.
SequelConnect emerged from a powerful foundation. Our parent organization, Sequel Med Tech, was co-founded by Dean Kamen, the renowned inventor of the first wearable insulin pump. This heritage in diabetes innovation gives us unparalleled insight into creating solutions that truly impact lives.
